单孔胸腔镜纤维板剥脱术治疗Ⅲ期结核性脓胸伴严重肋间隙狭窄
本研究纳入33例Ⅲ期结核性脓胸伴严重肋间隙狭窄患者,行单孔胸腔镜纤维板剥脱术联合部分肋骨切除及定制骨膜剥离器。结果显示该术式安全可行,无围术期死亡,1例中转开胸,术后肺功能明显改善;术前CT见壁层纤维板与胸壁间低密度线者术中出血更少。
要点
- 单孔胸腔镜纤维板剥脱术治疗Ⅲ期结核性脓胸伴严重肋间隙狭窄安全可行
- 术前CT见壁层纤维板与胸壁间低密度线者术中出血明显更少
- 术后 prolonged air leak(>5天)发生率为81.8%,需注意引流管理
核心结论
- 单孔胸腔镜纤维板剥脱术治疗Ⅲ期结核性脓胸伴严重肋间隙狭窄安全有效,术前CT显示增厚纤维板周围低密度线的患者可能是良好候选者。
研究设计与样本
- 回顾性分析2017年8月至2019年1月33例Ⅲ期结核性脓胸伴严重肋间隙狭窄患者,行单孔胸腔镜纤维板剥脱术联合部分肋骨切除及定制骨膜剥离器,分析术前术后胸部CT和肺功能检查。
主要发现
- 1例中转开胸,中位手术时间3.5小时(范围2.1-4.5小时),中位出血量500 mL(范围250-1000 mL),无围术期死亡。
- prolonged air leak(>5天)发生率为81.8%,中位术后住院4天(范围4-5天),所有患者带2根胸管出院,中位引流时间39天(范围30-60天)。
- 13例术前CT显示壁层纤维板与胸壁间低密度线,这些患者术中出血量明显低于无此影像表现者。
- 中位随访8个月(范围6-11.5个月),所有患者恢复良好,肺功能显著改善。
临床怎么用
- 对Ⅲ期结核性脓胸伴严重肋间隙狭窄患者,可考虑单孔胸腔镜纤维板剥脱术联合部分肋骨切除。
- 术前胸部CT评估壁层纤维板与胸壁间低密度线,有助于筛选术中出血风险较低的患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study explored the safety and feasibility of uniportal video-assisted thoracoscopic (VATS) decortication in patients presenting with stage III tuberculous empyema with severe rib crowding. METHODS: From August 2017 to January /2019, 33 patients with stage III tuberculous empyema and severe rib crowding underwent uniportal VATS decortication with partial rib resection and the use of a customized periosteal stripper. Preoperative and postoperative chest computed tomography (CT) imaging and pulmonary function testing were analyzed to evaluate the clinical significance of certain imaging findings and surgical efficacy. RESULTS: There was 1 conversion to open thoracotomy. Median operative time was 3.5 hours (range, 2.1-4.5 hours) and the median blood loss was 500 mL (range, 250-1000 mL). There were no perioperative mortalities. The incidence of prolonged air leaks (>5 days) was 81.8%. Median postoperative hospital stay was 4 days (range, 4-5 days). All patients were discharged with 2 chest tubes, and median duration drainage was 39 days (range, 30-60 days). The presence of a low-density line between the parietal fibrous pleural rind and chest wall was demonstrated on chest CT in 13 patients. Intraoperative blood loss was considerably lower in these patients compared with those without this imaging finding. Follow-up was complete in all patients over a median of 8 months (range, 6-11.5 months). All patients recovered well and achieved notable improvement in pulmonary function. CONCLUSIONS: Uniportal VATS decortication is safe and effective. Patients presenting with a low-density line around the thickened fibrous pleural rind on preoperative chest CT scan may be good candidates.
引用
- Zhou Y, Li X, Dai J, et al. Uniportal Thoracoscopic Decortication for Stage III Tuberculous Empyema With Severe Rib Crowding. Ann Thorac Surg. 2020. PMID: 33065049. doi:10.1016/j.athoracsur.2020.07.067
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。